Accenture Report Highlights What Patients Want in New Treatments; Two-Thirds Say: Better Outcomes, Not Brands When launching new products, pharmaceutical companies should focus more on evidence-based solutions than just the product or brand, according to a new report from Accenture on product launches in the pharmaceutical industry.   Among the key findings in the report, titled “Product Launch:…

Accenture identifies gaps in communication between pharmaceutical companies, healthcare professionals, and patients. New research from Accenture finds healthcare professionals’ lack of awareness is limiting the usage of patient services (such as adherence programs and remote monitoring) offered by pharmaceutical companies. This is a critical disconnect as patients and pharmaceutical companies primarily rely on healthcare professionals to…

Accenture and quantum software firm 1QBit collaborated with Biogen to develop a first-of-its-kind quantum-enabled molecular comparison application that could significantly improve advanced molecular design to speed up drug discovery for complex neurological conditions such as multiple sclerosis, Alzheimer’s, Parkinson’s and Lou Gehrig’s Disease. Researchers at Accenture Labs collaborated with 1QBit to create the new application which enhances Biogen’s existing molecule comparison method…

The vast majority of large pharmaceutical companies plan to increase their investment in patient-centric capabilities such as treatment adherence programs, remote patient monitoring, and medication delivery and support over the next two years, according to a new report from Accenture.   The report, titled “The Patient is IN: Pharma’s Growing Opportunity in Patient Services,” is…